Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Mutations in GBA1 are a common genetic risk factor for parkinsonism; however, penetrance is incomplete, and biomarkers of future progression to parkinsonism are needed. Both nigral sonography and striatal [ F]-FDOPA PET assay dopamine system health, but their utility and coherence in this context are unclear.

Objective: The aim of this study is to evaluate the utility and coherence of these modalities in GBA1-associated parkinsonism.

Methods: A total of 34 patients with GBA1 mutations (7 with parkinsonism) underwent both transcranial studies for substantia nigra echogenicity and [ F]-FDOPA PET to determine striatal tracer-specific uptake (K ).

Results: Larger nigral echogenic areas and reduced striatal K were exclusively observed in parkinsonian patients. Sonographic and PET measurements showed strong inverse correlations but only in individuals with clinical parkinsonism.

Conclusions: Close correspondence between nigral echogenicity and striatal presynaptic dopamine synthesis capacity observed only in GBA1 carriers with parkinsonism provides validation that these two modalities may conjointly capture aspects of the biology underlying clinical parkinsonism but raises questions about their utility as predictive tools in at-risk subjects. © 2022 International Parkinson and Movement Disorder Society.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940604PMC
http://dx.doi.org/10.1002/mds.28852DOI Listing

Publication Analysis

Top Keywords

f]-fdopa pet
8
utility coherence
8
parkinsonism
5
comparison transcranial
4
transcranial sonography
4
sonography f]-fluorodopa
4
pet
4
f]-fluorodopa pet
4
pet imaging
4
gba1
4

Similar Publications

Functional PET (fPET) identifies stimulation-specific changes of physiological processes, individual molecular connectivity and group-level molecular covariance. Since there is currently no consistent analysis approach available for these techniques, we present a toolbox for unified fPET assessment. The toolbox supports analysis of data obtained with a variety of radiotracers, scanners, experimental protocols, cognitive tasks and species.

View Article and Find Full Text PDF

This study assesses the clinical deployment of SubtlePET™, a commercial AI-based denoising algorithm, across three radiotracers-F-FDG, Ga-PSMA-11, and F-FDOPA-with the goal of improving image quality while reducing injected activity, technologist radiation exposure, and scan time. A retrospective analysis on a digital PET/CT system showed that SubtlePET™ enabled dose reductions exceeding 33% and time savings of over 25%. AI-enhanced images were rated interpretable in 100% of cases versus 65% for standard low-dose reconstructions.

View Article and Find Full Text PDF

Objective: This study aims to identify the possibility of cross-modality image-to-image translation from magnetic resonance (MR) to synthetic positron emission tomography (PET)/MR fusion images using conditional generative adversarial networks (CGAN).

Methods: Retrospective study was conducted involving 32 simultaneous 6-[F]-fluoro-L-3,4-dihydroxyphenylalanine (F-FDOPA) PET/MR imaging examinations from 27 patients diagnosed with brain cancer. We applied paired axial T1-weighted contrast MR (T1C) and PET/T1C fusion images to translate from T1C to synthetic PET/T1C fusion images using the Pix2Pix algorithm of CGAN.

View Article and Find Full Text PDF

Associations can be learned incrementally, via reinforcement learning (RL), or stored instantly in working memory (WM). While WM is fast, it is also capacity-limited and effortful. Striatal dopamine may promote WM, by facilitating WM updating and effort exertion and also RL, by boosting plasticity.

View Article and Find Full Text PDF

Purpose: To compare the diagnostic performance between 18 F-N-3-fluoropropyl-2beta-carbon ethoxy-3beta-4-iodophenyl nortropane ( 18 F-FP-CIT) and 6- 18 F-fluoro-L-dopa ( 18 F-FDOPA) PET/CT in patients with early Parkinson disease (PD).

Methods: This study included 42 de novo PD patients who were clinically diagnosed at a university-affiliated tertiary hospital in South Korea and underwent 18 F-FP-CIT and 18 F-FDOPA PET imaging from November 2019 and March 2024. 18 F-FP-CIT and 18 F-FDOPA PET CT images were assessed at the initial diagnosis.

View Article and Find Full Text PDF